The dog treated with RECONCILE chewable tablets was subsequently diagnosed with vestibular disease and the control dog had a history of recurrent hind leg weakness. In a European multi-site study, 234 dogs were treated with daily doses of fluoxetine chewable tablets ranging from 0.25 mg/kg to 4 mg/kg. One dog treated with a daily dose of 0.4 mg/kg for one month experienced one seizure one week after discontinuing therapy.
RPRâs core mission is to reinforce the REALTORÂ®'s value in the marketplace by keeping them ahead of the technology curve and better able to serve todayâs technology empowered consumer. Realtors Property ResourceÂ® (RPRÂ®) is NAR's exclusive online real estate database. RPRâs core mission is to reinforce the REALTORÂ®'s value in the marketplace by keeping them ahead of the technology curve and better able to serve todayâs technology empowered consumer.
The goal of the CNPR Training Program is to prepare candidates for a career in pharmaceutical sales. A CNPRâ¢ (Certified National Pharmaceutical Representative) is a federally trademarked certification which can be obtained by acquiring the necessary knowledge in pharmacology, medical terminology, physiology, and regulations for selling pharmaceuticals. The CNPRâ¢ examination is dedicated to increasing the professional level of NAPSRâ¢ (National Association of Pharmaceutical Sales Representativesâ¢) members and to developing meaningful and ethical standards fully accepted by its members and members of the pharmaceutical community.